J.M. Arbour’s Pfizer PFE Stock Holding History

J.M. Arbour’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Buy	10,443 +1,286	+14%	+$33.6K	0.22%	112
2026 Q1	$257K	Buy	9,157 +351	+4%	+$9.35K	0.25%	101
2025 Q4	$219K	Buy	+8,806	New	+$222K	0.22%	105

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

J.M. Arbour's PFE Position: Q2 2026 in Review

J.M. Arbour increased its Pfizer (PFE) stake by 14% in Q2 2026, buying an estimated $33.6K and bringing the position to 10,443 shares worth $251K. The position accounts for 0.22% of the portfolio, ranked #112.

J.M. Arbour first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $257K in Q1 2026. 2,840 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

J.M. Arbour held 10,443 shares of Pfizer worth $251K as of Q2 2026.
J.M. Arbour bought 1,286 Pfizer shares in Q2 2026, an estimated $33.6K.
Pfizer made up 0.22% of J.M. Arbour's portfolio in Q2 2026, its #112 holding.
J.M. Arbour first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
J.M. Arbour's Pfizer position peaked at $257K in Q1 2026.
2,840 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on J.M. Arbour's 13F filing for Q2 2026, filed 14 Aug 2026.